LEUTX and neuroepithelial neoplasm: Notably, within our cohort, we discovered two cases of neuroepithelial tumors with CIC::LEUTX fusion that demonstrated prolonged progression-free survival (PFS) and presented with unique, unassigned methylation signatures.